Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.
about
What we should know about portal vein thrombosis in cirrhotic patients: a changing perspectivePregnancy and vascular liver diseaseMesenteric venous thrombosisReview article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein ThrombosisTamoxifen-associated portal vein thrombosis causing severe oesophageal variceal bleeding.High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosisVenous thromboembolism in patients with essential thrombocythemia and polycythemia vera.The JAK2 exon 12 mutations: a comprehensive review.Etiology and long-term outcome of extrahepatic portal vein obstruction in children.Portal vein thrombosis: etiology and clinical outcome of cirrhosis and malignancy-related non-cirrhotic, non-tumoral extrahepatic portal venous obstruction.Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosisTreatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder.Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies.Elevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome.Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm.JAK2V617F: Is It Sufficient as a Single Player in Splanchnic Venous Thrombosis?Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms.Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center studyCauses of adult splanchnic vein thrombosis in the mediterranean area.Transient ischemic attacks as the first presentation of JAK2-V617F positive chronic myeloproliferative neoplasm.Hepatic manifestations in hematological disorders.Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes.Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment.Treatment options for essential thrombocythemia and polycythemia vera.JAK2V617F mutation in patients with thrombosis: to screen or not to screen?Special indications for vitamin K antagonists: a review.Viral cirrhosis: an overview of haemostatic alterations and clinical consequencesThrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management.Splanchnic vein thrombosis in myeloproliferative neoplasms.Are MPNs vascular diseases?WHO classification of myeloproliferative neoplasms (MPN): A critical update.Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction.Budd-Chiari syndrome/hepatic venous outflow tract obstruction.Thrombosis of the Abdominal Veins in Childhood.JAK2 mutation in patients with splanchnic venous thrombosis: a pilot study from India.
P2860
Q26827793-61E9D9D2-1F40-431D-B617-0BF2C8AD1A89Q27025448-915CAD72-EF16-4DFC-BB43-E2A2F0FE1FEFQ28080511-C3EB86C4-4116-403A-99F5-E1881AEE63F7Q30244631-DC31118B-A225-4E24-98F9-E1DEB6860D71Q30303071-843A90D5-06E7-4CED-9746-DCA9C491F8DCQ33166159-EE786C11-7073-4533-A84D-B6704CCC157BQ33393259-6022F154-9A7E-4D5F-AB07-E33A08BD79A8Q33398180-81169D91-13D6-4E17-8E57-B05382AD50CAQ34192739-90B6D425-96F3-480F-AAC8-E474D1BF6321Q34213771-3A495200-E4CE-4614-93FA-6A54C4B3D179Q34225697-D21A4A24-8032-4DB8-BABA-DDFF03D46DFBQ34247430-57ABAA49-BF5A-45D8-BF21-4BE57F7FBCC5Q34367022-DA7372EF-5BF3-4EC3-904D-B93B4F4E7B47Q34502105-ED76E9FD-FE70-4764-8FDF-F8A53E65A54BQ34635408-6AEB57E9-40BF-4D89-8384-19359B50F548Q35041677-CCCC2BF5-6844-4059-B197-F53EE2110828Q35296834-4FA08C51-4F5A-4268-A556-CEB038B8A746Q35433259-B0E6E1FC-23DE-4D6E-AECA-C7D7FD7E8188Q35433425-F7142A6F-0B54-4ACB-9495-5B17593F32A5Q35600943-05AD2478-02F0-4912-9175-9B5C269651E0Q35640769-A845728F-AC0D-407C-859F-5AD47A4D6D46Q36106171-82F2AE98-DE4C-4379-A266-D33FC14B2066Q36765838-BAA5590D-946D-4D54-B580-548E4DCF295AQ36841714-43357023-31A6-4B74-AC38-60FFA7900F11Q37142210-70BB1372-A5C3-4C55-95D7-C7E5AE778E81Q37672471-FBCC9A71-6A0F-4DF5-AC05-60D0B4EE55CDQ37810107-2DACFA84-D326-4AB8-BA1A-26B15134B30AQ37813820-63955138-7FFE-4D97-B840-5B5953EE27DAQ37850350-1D7118AF-C75C-4327-A696-527F0F08F36EQ37854462-5102E0C6-79E1-4855-B11D-C074104C021CQ38100371-0DE85129-CD27-4094-94EC-5E88D400CD00Q38121635-BF39B49C-0F90-4152-8E0D-18EA2C232213Q38137750-7F642D8E-3DC8-4F80-BEAA-2ADC919DFD52Q38154519-678E1D01-87B8-4FAE-888C-CE0BC2C4DEF1Q38187675-0100BB38-29B2-48E2-B40E-1669B02E1273Q39276259-B382A626-0C58-46FF-93D1-20DD24476B44Q39385436-BC970B13-6349-407E-BB3E-1C0FE3AF8A7EQ39419938-DE919CCB-3880-4F73-9D8A-851F1DC6B937Q41457449-3A1CC8D2-75B4-4D23-B415-5A3E5C1F1C0CQ43184009-C67A0575-271F-49BE-848A-EA83956F1500
P2860
Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Role of the JAK2 mutation in t ...... in splanchnic vein thrombosis.
@en
Role of the JAK2 mutation in t ...... in splanchnic vein thrombosis.
@nl
type
label
Role of the JAK2 mutation in t ...... in splanchnic vein thrombosis.
@en
Role of the JAK2 mutation in t ...... in splanchnic vein thrombosis.
@nl
prefLabel
Role of the JAK2 mutation in t ...... in splanchnic vein thrombosis.
@en
Role of the JAK2 mutation in t ...... in splanchnic vein thrombosis.
@nl
P2093
P356
P1433
P1476
Role of the JAK2 mutation in t ...... in splanchnic vein thrombosis.
@en
P2093
Alessandra Dell'Era
Federica Fabris
Gaetano Bergamaschi
Giovanni Barosi
Massimo Primignani
Raffaella Reati
Umberto Gianelli
P304
P356
10.1002/HEP.21435
P407
P577
2006-12-01T00:00:00Z